Developing specialized cancer, CNS and infectious disease pharmaceutical products

Nanopharmaceutics current partners and collaborators include:

  • Alchem Laboratories Corporation

  • CPA Global

  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (ICP)

  • Discovery Cure Institute, Inc. (DCI)

  • Finnegan, Henderson, Farabow, Garrett & Dunner, LLP


  • National Cancer Institute (NCI) / National Institutes of Health (NIH)

  • Registrar Corp.

  • Pace Analytical Labs